Literature DB >> 27142712

Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Saskia Semmlack1, Sarah Tschudin-Sutter2, Andreas F Widmer2, Martina Valença3, Stephan Rüegg4, Stephan Marsch1, Raoul Sutter5,6.   

Abstract

Infections are frequent in patients with status epilepticus (SE). It remains unclear if infections merely reflect severity of the underlying illness or if they independently predict unfavourable course and outcome. We sought to determine if infections diagnosed within 48 h from SE onset are independent predictors of poor course and outcome and if their effect is modified by clinical characteristics. From 2005 to 2014, pertinent clinical data, microbiology, death, return to functional baseline, and unfavourable outcome in survivors were assessed in SE patients treated in the intensive care units (ICU) of an academic medical care center. Among 352 consecutive patients, 81 (23 %) were diagnosed with infections at SE onset. In-hospital mortality was higher in patients with infections (26 %) compared to 10 % in patients without infections (p < 0.001). Infections at SE onset increased the odds ratios (OR) for prolonged ICU (OR = 4.1, 95 %CI 1.87-6.74) and hospital stay (OR = 5.4, 95 %CI 1.24-9.63), refractory SE (OR = 3.1, 95 %CI 1.79-5.34), prolonged mechanical ventilation (OR = 3.8, 95 %CI 2.15-6.79), no return to functional baseline (OR = 2.1, 95 %CI 1.10-4.02), unfavourable outcome in survivors (OR = 2.0, 95 %CI 1.02-3.81), and death (OR = 2.5, 95 %CI 1.28-4.99). All associations were independent of confounders and without significant effect modification by age, level of consciousness, types and severity of SE, and etiologies. In addition, the number of infections increased the probability of unfavourable course and outcome. Infections at SE onset are frequent and associated with prolonged medical care, treatment refractory SE, higher morbidity and mortality independently of potential confounders calling for the evaluation of treatment strategies.

Entities:  

Keywords:  Infections; Neurocritical care; Outcome; Status epilepticus; Systemic inflammation

Mesh:

Substances:

Year:  2016        PMID: 27142712     DOI: 10.1007/s00415-016-8140-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

Review 2.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

3.  Infections in status epilepticus: a retrospective 5-year cohort study.

Authors:  Johan Zelano; Fredrik Möller; Judith Dobesberger; Eugen Trinka; Eva Kumlien
Journal:  Seizure       Date:  2014-05-02       Impact factor: 3.184

Review 4.  Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability.

Authors:  Annamaria Vezzani; Barbara Viviani
Journal:  Neuropharmacology       Date:  2014-11-08       Impact factor: 5.250

5.  A clinical score for prognosis of status epilepticus in adults.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Edward B Bromfield
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

Review 6.  A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus.

Authors:  Eugen Trinka; Hannah Cock; Dale Hesdorffer; Andrea O Rossetti; Ingrid E Scheffer; Shlomo Shinnar; Simon Shorvon; Daniel H Lowenstein
Journal:  Epilepsia       Date:  2015-09-04       Impact factor: 5.864

7.  Refractory status epilepticus: a prospective observational study.

Authors:  Jan Novy; Giancarlo Logroscino; Andrea O Rossetti
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

8.  Independent external validation of the status epilepticus severity score.

Authors:  Raoul Sutter; Peter W Kaplan; Stephan Rüegg
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

9.  Cytokine production in blood mononuclear cells from epileptic patients.

Authors:  R Pacifici; L Paris; S Di Carlo; A Bacosi; S Pichini; P Zuccaro
Journal:  Epilepsia       Date:  1995-04       Impact factor: 5.864

10.  EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness.

Authors:  M Privitera; M Hoffman; J L Moore; D Jester
Journal:  Epilepsy Res       Date:  1994-06       Impact factor: 3.045

View more
  6 in total

Review 1.  Healthcare-Associated Infections in the Neurocritical Care Unit.

Authors:  Katharina M Busl
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-27       Impact factor: 5.081

2.  Emergency First-Line Anti-Seizure Medication for Seizures and Status Epilepticus: What is Going Wrong, Doctor?

Authors:  Raoul Sutter
Journal:  CNS Drugs       Date:  2018-10       Impact factor: 5.749

Review 3.  Systemic Complications Following Status Epilepticus.

Authors:  Maximiliano A Hawkes; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-07       Impact factor: 5.081

Review 4.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497

5.  First-Response ABCDE Management of Status Epilepticus: A Prospective High-Fidelity Simulation Study.

Authors:  Paulina S C Kliem; Kai Tisljar; Sira M Baumann; Pascale Grzonka; Gian Marco De Marchis; Stefano Bassetti; Roland Bingisser; Sabina Hunziker; Stephan Marsch; Raoul Sutter
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

Review 6.  [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology].

Authors:  F Rosenow; J Weber
Journal:  Nervenarzt       Date:  2021-03-22       Impact factor: 1.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.